IOL CHEMICALS & PHARM. | KWALITY PHARMA | IOL CHEMICALS & PHARM./ KWALITY PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 43.8 | 31.2% | View Chart |
P/BV | x | 1.6 | 2.6 | 59.8% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. KWALITY PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
KWALITY PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ KWALITY PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 639 | 84.0% | |
Low | Rs | 272 | 266 | 102.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 241.8 | 156.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 18.6 | 127.6% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 33.0 | 95.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 193.2 | 132.9% | |
Shares outstanding (eoy) | m | 58.71 | 10.38 | 565.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.9 | 57.3% | |
Avg P/E ratio | x | 17.1 | 24.3 | 70.1% | |
P/CF ratio (eoy) | x | 12.8 | 13.7 | 93.5% | |
Price / Book Value ratio | x | 1.6 | 2.3 | 67.3% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 4,693 | 505.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 282 | 597.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 2,510 | 883.2% | |
Other income | Rs m | 256 | 29 | 870.8% | |
Total revenues | Rs m | 22,427 | 2,540 | 883.1% | |
Gross profit | Rs m | 2,257 | 442 | 510.6% | |
Depreciation | Rs m | 462 | 150 | 308.6% | |
Interest | Rs m | 165 | 66 | 249.2% | |
Profit before tax | Rs m | 1,887 | 256 | 737.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 63 | 786.7% | |
Profit after tax | Rs m | 1,391 | 193 | 721.7% | |
Gross profit margin | % | 10.2 | 17.6 | 57.8% | |
Effective tax rate | % | 26.2 | 24.6 | 106.7% | |
Net profit margin | % | 6.3 | 7.7 | 81.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,072 | 466.5% | |
Current liabilities | Rs m | 5,025 | 1,259 | 399.0% | |
Net working cap to sales | % | 20.9 | 32.4 | 64.7% | |
Current ratio | x | 1.9 | 1.6 | 116.9% | |
Inventory Days | Days | 43 | 17 | 255.6% | |
Debtors Days | Days | 8 | 1,042 | 0.8% | |
Net fixed assets | Rs m | 11,017 | 1,464 | 752.4% | |
Share capital | Rs m | 587 | 104 | 565.8% | |
"Free" reserves | Rs m | 14,490 | 1,901 | 762.1% | |
Net worth | Rs m | 15,077 | 2,005 | 751.9% | |
Long term debt | Rs m | 0 | 273 | 0.0% | |
Total assets | Rs m | 20,684 | 3,536 | 584.9% | |
Interest coverage | x | 12.5 | 4.9 | 255.7% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 151.0% | |
Return on assets | % | 7.5 | 7.3 | 102.8% | |
Return on equity | % | 9.2 | 9.6 | 96.0% | |
Return on capital | % | 13.6 | 14.1 | 96.3% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 7.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 188 | 0.0% | |
Fx inflow | Rs m | 5,930 | 1,198 | 495.1% | |
Fx outflow | Rs m | 6,052 | 287 | 2,108.9% | |
Net fx | Rs m | -122 | 911 | -13.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 414 | 295.5% | |
From Investments | Rs m | -1,200 | -484 | 247.7% | |
From Financial Activity | Rs m | -41 | 10 | -413.5% | |
Net Cashflow | Rs m | -18 | -61 | 30.3% |
Indian Promoters | % | 48.2 | 54.8 | 87.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 45.2 | 114.7% | |
Shareholders | 130,003 | 5,695 | 2,282.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | KWALITY PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | -0.98% | 0.97% |
1-Month | 5.64% | 20.20% | 2.08% |
1-Year | -1.14% | 37.45% | 55.37% |
3-Year CAGR | -12.91% | 94.64% | 15.04% |
5-Year CAGR | 16.34% | 66.64% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the KWALITY PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of KWALITY PHARMA the stake stands at 54.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of KWALITY PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
KWALITY PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of KWALITY PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.